Account
Hero background pattern

We’ll launch your pharmaceuticals to new heights

Specialist and experienced pricing and market access consultancy

Insider Insights

Worldwide: New Coalition to improve access to canc…

According to the UICC, “priority will be given to medicines currently on the WHO Essential Medicin…
Read more
Insider Insights

World’s first CRISPR medicine approved in UK for…

The MHRA grants conditional approval to Casgevy, the first-ever CRISPR gene-editing therapy for sick…
Read more
Articles

World Orphan Drug Congress Europe 2023 REPORT

We summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H…
Read more
161 Pharma & biotech companies worked with
11 We work with 11 of the top 20 pharma companies
95% Positive feedback from our training courses
57 We’ve supported pricing and access strategies in 57 countries worldwide

Our Services

From launching your product to access training

Launch Implementation

We will develop and implement a successful launch strategy for your product.

Find out more

Price Optimization

We build payer focussed pricing and market access strategies to enable commercial success.

Find out more

Market Access Training

We provide engaging training solutions that ensures your organisation stays ahead of the ever-changing market access landscape.

Find out more

Our mission

To enable patient access to your products

Unifying our internal strengths and external partnerships helps solve your pricing and market access challenges to drive patient access of your pharmaceutical products.

Our strategy

We have the expertise to get your products into doctors hands

Clearly and concisely communicate key scientific, economic and commercial messages to enable company employees to effectively communicate the product’s value.

How we work

Bespoke approach

Individual solutions to suit you

Flexible

We adapt our working style to reflect your needs

Real-world pharma experience

We have a wealth of practical knowledge & experience within the pharma industry & HTA bodies

Responsive

We react quickly and effectively to provide the best support possible

Updates & News

Latest research and publications

16.07.2024
Joint Nordic HTA Bodies produce draft process guid…

The collaboration is aimed at enhancing HTA reports, facilitating resource and knowledge sharing and…

Read more
Insider Insights
11.07.2024
AIFA publishes report on pharmaceutical national a…

Increase in net spending and challenges in balancing healthcare budgets highlighted in AIFA’s latest…

Read more
Insider Insights
09.07.2024
HAS relaxes evidence requirements under certain co…

New doctrine accelerates drug development for rare diseases and oncology by adjusting evidence requi…

Read more
Insider Insights
08.07.2024
New German Medicines Research Act: confidential re…

Germany’s new Medicines Research Act allows confidential rebates for pharma companies, but recent am…

Read more
Insider Insights
04.07.2024
Hemgenix becomes the first treatment to enter NHS …

New ground-breaking gene therapy for haemophilia B enters NHS England’s Innovative Medicines Fund, o…

Read more
Insider Insights
03.07.2024
The transformation of healthcare through personali…

The rise of personalised medicine is revolutionizing healthcare, prompting a re-evaluation of tradit…

Read more
News
26.06.2024
Annual CSR Report 2023/24

Our Corporate Social Responsibility (CSR) Team will focus on employee wellbeing, the local community…

Read more
News
18.06.2024
HTAi Annual Meeting 2024

We summarise the key discussions from HTAi 2024, with a focus on sustainability, networks and innova…

Read more
Articles
18.06.2024
What does it take to secure access to digital heal…

Article originally published 11th August 2022, updated 18th June 2024. Introduction Digital health a…

Read more
Visit our resource library

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.